Literature DB >> 2521957

Point mutational inactivation of the retinoblastoma antioncogene.

J M Horowitz1, D W Yandell, S H Park, S Canning, P Whyte, K Buchkovich, E Harlow, R A Weinberg, T P Dryja.   

Abstract

The retinoblastoma (Rb) antioncogene encodes a nuclear phosphoprotein, p105-Rb, that forms protein complexes with the adenovirus E1A and SV40 large T oncoproteins. A novel, aberrant Rb protein detected in J82 bladder carcinoma cells was not able to form a complex with E1A and was less stable than p105-Rb. By means of a rapid method for the detection of mutations in Rb mRNA, this defective Rb protein was observed to result from a single point mutation within a splice acceptor sequence in J82 genomic DNA. This mutation eliminates a single exon and 35 amino acids from its encoded protein product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521957     DOI: 10.1126/science.2521957

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  103 in total

1.  Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression.

Authors:  H A Hirsch; L Gu; R W Henry
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

Authors:  P A Hamel; R M Gill; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

4.  Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

Authors:  Z Onadim; A Hogg; P N Baird; J K Cowell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding.

Authors:  Y Qian; C Luckey; L Horton; M Esser; D J Templeton
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

6.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

7.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 8.  Molecular basis for therapy resistance.

Authors:  Per E Lønning
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

9.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

10.  The retinoblastoma gene product regulates Sp1-mediated transcription.

Authors:  S J Kim; U S Onwuta; Y I Lee; R Li; M R Botchan; P D Robbins
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.